Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children

被引:0
|
作者
Beatriz Larru
Carmen de Mendoza
José Ma Bellón
Ma Isabel de José
Ma José Mellado
Vincent Soriano
Ma Angeles Muñoz-Fernandez
José T Ramos
机构
[1] Hospital General Universitario "Gregorio Marañón",Laboratorio de Inmuno
[2] Hospital "Carlos III",Biología Molecular
[3] Hospital Universitario "La Paz",Enfermedades Infecciosas
[4] Hospital "Carlos III",Pediatría
[5] Hospital Universitario "12 de Octubre",Infecciosas
来源
关键词
Viral Load; Ritonavir; Virological Response; Amprenavir; Salvage Regimen;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-I infected children
    Larru, Beatriz
    de Mendoza, Carmen
    Bellon, Jose Ma
    de Jose, Ma Isabel
    Mellado, Ma Jose
    Soriano, Vincent
    Munoz-Fernandez, Ma Angeles
    Ramos, Jose T.
    BMC INFECTIOUS DISEASES, 2007, 7 (1)
  • [2] Predictive value of HIV-1 protease genotype and virtual phenotype on the virological response to lopinavir/ritonavir-containing salvage regimens
    Loutfy, MR
    Raboud, JM
    Walmsey, SL
    Saskin, R
    Montaner, JS
    Hogg, RS
    Thompson, CA
    Harrigan, PR
    ANTIVIRAL THERAPY, 2004, 9 (04) : 595 - 602
  • [3] Integrase inhibitors in salvage therapy regimens for HIV-1 infection
    Koelsch, Kersten K.
    Cooper, David A.
    CURRENT OPINION IN HIV AND AIDS, 2009, 4 (06) : 518 - 523
  • [4] Efficacy of lopinavir/ritonavir (lop/r)-containing salvage regimens in HIV-1 infected patients
    Badri, S
    Falusi, O
    Max, B
    Barker, D
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1204 - 1204
  • [5] HIV-1 resistance patterns to integrase inhibitors in Chilean patients with virological failure on raltegravir-containing regimens
    Ferrer, Pablo
    Rodriguez, Consuelo
    Sciaraffia, Alicia
    Tordecilla, Rocio
    Ramos, Veronica
    Duran, Magdalena
    Beltran, Carlos
    Afani, Alejandro
    JOURNAL OF VIRUS ERADICATION, 2020, 6 (03)
  • [6] Clinical use of HIV-1 resistance genotyping.: Predictive factors of poor virological evolution in salvage treatments
    Riera-Jaume, Melcior
    Peñaranda-Vera, Maria
    Angels Ribas-Blanco, Ma.
    Murillas-Angoiti, Javier
    Campins, Antoni
    Salas-Aparicio, Ana
    Leyes-García, María
    Pareja-Bezares, Antonio
    Pérez, José Luis
    Villalonga-Pieras, Concepción
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2006, 24 (04): : 225 - 231
  • [7] INHIBITORS OF HIV-1 PROTEASE
    MEEK, TD
    JOURNAL OF ENZYME INHIBITION, 1992, 6 (01): : 65 - 98
  • [8] HIV-1 protease inhibitors
    Eron, JJ
    CLINICAL INFECTIOUS DISEASES, 2000, 30 : S160 - S170
  • [9] HIV-1 protease inhibitors
    不详
    DRUG DISCOVERY TODAY, 2001, 6 (08) : 438 - 439
  • [10] INHIBITORS OF HIV-1 PROTEASE
    DREYER, GB
    CARR, T
    LAMBERT, DM
    TOMASZEK, T
    MEEK, T
    CACCIAVILLANI, E
    PETTEWAY, SR
    MOORE, M
    DEBOUCK, C
    METCALF, BW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 83 - MEDI